- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03340584
The Clinical Observation on Taping After Total Knee Replacement (taping)
July 24, 2019 updated by: Song-he Jiang, Second Affiliated Hospital of Wenzhou Medical University
The Effectiveness of the Nine Castle Net Format Taping After Total Knee Replacement in Early Postoperative Rehabilitation Period. A Randomized Controlled Trial
The investigators will conduct a single-blind, randomized controlled trial of 100 patients with total knee replacement.
Patients will be randomly assigned into a control group and an intervention group.Both groups received same rehabilitation procedures after surgery,except intervention group also received taping applications throughout all rehabilitation period.Then, the patients will be reevaluated to determine changes in lower extremity function, edema, pain,knee range of motion, and muscle strength of quadriceps femoris and hamstring.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Songhe Jiang
- Phone Number: 8613600661860
- Email: 863191168@qq.com
Study Locations
-
-
Zhejiang
-
Wenzhou, Zhejiang, China, 325000
- Recruiting
- Songhe Jiang
-
Contact:
- Songhe Jiang, Professor
- Phone Number: 13600661860
- Email: 863191168@qq.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- soft-tissue swelling and pain after total knee replacement
- agree to participate the study and signing of informed consent
Exclusion Criteria:
- severe cognitive and language barriers that can not be used to evaluate patients with pain and swelling
- failure of important organs, such as heart, lung, liver and kidney
- deep venous thrombosis
- thrombophlebitis
- varicose veins (stage II-IVaccording to Marshall) and venous insufficiency (stadium 2-3 according to Widmer)
- participants with infection in the areas close to the knee joint, or allergy to tape
- enrollment in another clinical trial involving physical therapy or an investigational drug
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: The intervention group
The intervention group will be received the Nine Castle Net Format taping and the traditional rehabilitation throughout all hospitalization period.We will exchange the new taping for Every two days.
|
The intervention group received traditional rehabilitation and Taping throughout all rehabilitation period.The taping including a Nine Castle Net Format of taping in both side of surgery knee.We will exchange the new taping for every two days, for a week.Traditional rehabilitation included occupational therapy and physical therapy, patients took part in the traditional rehabilitation training for 30 minutes each day, for a week.
|
Other: The control group
The control group will be received the traditional rehabilitation during the hospitalization period.The traditional rehabilitation included occupational therapy and physical therapy.
|
traditional rehabilitation included occupational therapy and physical therapy, patients took part in the traditional rehabilitation training for 30 minutes each day, for a week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline Knee Edema at 1 week
Time Frame: Baseline and at 1 week
|
Leg Circumference Measurements
|
Baseline and at 1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline Activities of Daily Living (ADL) at 1 week
Time Frame: Baseline and at 1 week
|
The Barthel index
|
Baseline and at 1 week
|
Change from Baseline Knee Pain at 1 week
Time Frame: Baseline and at 1 week
|
Numeric Pain Rating Scale(NPRS),Numeric Pain Rating Scale on a 1(no pain)to 10(worst pain imaginable)scale, 0 No pain,1 2 3 Mild pain, 4 5 6 Moderate pain,7 8 9 10 Worst possible pain
|
Baseline and at 1 week
|
Change from Baseline Knee range of motion at 1 week
Time Frame: Baseline and at 1 week
|
The Range of Motion Measurements
|
Baseline and at 1 week
|
Change from Baseline muscle strength of quadriceps femoris and hamstring at 1 week
Time Frame: Baseline and at 1 week
|
Manual Muscle Test(MMT)
|
Baseline and at 1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 25, 2017
Primary Completion (Anticipated)
December 30, 2020
Study Completion (Anticipated)
December 30, 2020
Study Registration Dates
First Submitted
November 8, 2017
First Submitted That Met QC Criteria
November 9, 2017
First Posted (Actual)
November 13, 2017
Study Record Updates
Last Update Posted (Actual)
July 25, 2019
Last Update Submitted That Met QC Criteria
July 24, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2017PT1025
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Total Knee Replacement
-
Central DuPage HospitalTerminatedTotal Knee Replacement | Replacement, Total Knee | Arthroplasty, Knee ReplacementUnited States
-
Ottawa Hospital Research InstituteThe Ottawa Hospital Academic Medical AssociationCompletedTotal Hip Replacement | Total Knee ReplacementCanada
-
Singapore General HospitalCompletedTotal Knee Arthroplasty | Total Knee ReplacementSingapore
-
Istanbul UniversityCompleted
-
Istanbul UniversityCompletedTotal Knee Arthroplasty | Total Knee ReplacementTurkey
-
Mayo ClinicStryker OrthopaedicsCompletedArthroplasty, Replacement, Knee | Total Knee ReplacementUnited States
-
University of North Carolina, Chapel HillNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedKnee Arthroplasty, Total | Knee Replacement, TotalUnited States
-
Mayo ClinicCompletedKnee Total Joint Replacement | Hip Total Joint ReplacementUnited States
-
Isfahan University of Medical SciencesCompletedTotal Knee Replacement | Total Knee Arthroplasty(TKA)Iran, Islamic Republic of
-
Assiut UniversityNot yet recruitingTotal Knee Replacement